Allergic Rhinoconjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinoconjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 trial assessing the safety and efficacy of a recombinant grass pollen allergen cocktail for allergic rhinoconjunctivitis has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis [Phase 4]
Phase 4 trial assessing safety and efficacy of House Dust Mite Allergen Extract for allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) [Phase 1, Phase 2]
Pharmacokinetic study of bilastine in children aged 2 to under 12 with allergic rhinoconjunctivitis or chronic urticaria (Phase 1/2). The tr…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: ToleroMune Ragweed Follow up Study
Update on a completed follow-up clinical trial of ToleroMune Ragweed for ragweed allergy with rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: PURETHAL Grasses Rush Study [Phase 4]
Phase 4 trial update for HAL Allergy's PURETHAL Grasses Rush immunotherapy in allergic rhinitis and allergic rhinoconjunctivitis; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients [Phase 2]
A Phase 2 study evaluating high-dose PURETHAL mite extract for allergic rhinitis and allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]
Phase 2 dose-finding study of Depigoid Birch in patients with allergic rhinitis, rhinoconjunctivitis, with or without asthma has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of grass pollen allergen immunotherapy delivered via epicutaneous administration i…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating the safety of ToleroMune Ragweed in ragweed-allergic individuals with rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the safety of ToleroMune for house dust mite allergy in subjec…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC)
Clinical trial update notes completion of a conjunctival allergen challenge study in individuals with allergic rhinoconjunctivitis using the…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Efficacy and Safety of Grass Pollen Sublingual Immunotherapy [Phase 2, Phase 3]
This clinical trial update evaluates the efficacy and safety of Grass pollen sublingual immunotherapy for allergic rhinoconjunctivitis in Ph…
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis [Phase 3]
This is an update on a Phase 3 randomized, double-blind, placebo-controlled trial of Oralgen Grass Pollen for allergic rhinoconjunctivitis.